$2.33
0[0.00%]
At close: May 17
$2.33
0[0.00%]
After Hours: 9:18AM EDT
Oramed Pharmaceuticals
(NASDAQ:ORMP)Latest News for Oramed Pharmaceuticals Stock (NASDAQ:ORMP)
Oramed Pharmaceuticals Stock (NASDAQ: ORMP)
Categories: All
Wednesday, May 15, 2024
Friday, February 02, 2024
Tuesday, January 23, 2024
- Oramed Pharmaceuticals Parties Intend For JV To Initiate Phase 3 Oral Insulin Trial In The U.S.; Oramed Will Be Entitled To Receive A 3% Royalty On Gross Revenues Of JV Generated From Oramed Related AssetsCharles Gross - Jan 23, 2024, 4:51PM
- Oramed Pharmaceuticals Said On Jan 22, Co And Unit Entered Into Joint Venture Agreement With Hefei Tianhui Biotech And Technowl; Oramed And HTIT Will Initially Hold Equal Shares In JV, With Each Owning 50% Of EquityCharles Gross - Jan 23, 2024, 4:50PM
Friday, September 22, 2023
Thursday, September 21, 2023
- Scilex Assumed $100M In Debt Owed To Oramed Pharmaceuticals And Issued A Promissory Note And Warrants To Oramed As Part Of The Securities Transfer.Benzinga Newsdesk - Sep 21, 2023, 4:15PM
- Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc.Benzinga Newsdesk - Sep 21, 2023, 4:15PM
Wednesday, September 13, 2023
Wednesday, August 02, 2023
Friday, June 23, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jun 23, 2023, 1:37PM
- Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jun 23, 2023, 12:20PM
- Dow Tumbles 250 Points; CarMax Posts Upbeat ResultsLisa Levin - Jun 23, 2023, 9:51AM
Wednesday, May 17, 2023
Tuesday, May 16, 2023
Monday, May 15, 2023
- Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - May 15, 2023, 1:45PM
- Why Oramed Pharmaceuticals Shares Are Trading Higher TodayVandana Singh - May 15, 2023, 11:18AM
- Oramed Announces That Its Chinese Partner, HTIT, Has Successfully Completed A Phase 3 Oral Insulin Clinical Trial And Submitted A Marketing Authorization Application In ChinaBenzinga Newsdesk - May 15, 2023, 9:07AM
Monday, May 01, 2023
Thursday, March 16, 2023
Thursday, February 09, 2023
Thursday, January 19, 2023
Tuesday, January 17, 2023
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Jan 17, 2023, 12:17PM
- Oramed Pharmaceuticals shares are trading lower after HC Wainwright & Co. downgraded the stock from Buy to Neutral.Michael Horton - Jan 17, 2023, 12:14PM
- Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023Benzinga Insights - Jan 17, 2023, 10:01AM
- HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to NeutralBenzinga Newsdesk - Jan 17, 2023, 6:12AM
Thursday, January 12, 2023
- Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%Lisa Levin - Jan 12, 2023, 2:28PM
- Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jan 12, 2023, 1:19PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jan 12, 2023, 12:31PM
- US Stocks Turn Higher; Dow Jumps 200 PointsLisa Levin - Jan 12, 2023, 12:11PM
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Jan 12, 2023, 11:59AM
- Dow Drops 150 Points; US Inflation Rate Slows In DecemberLisa Levin - Jan 12, 2023, 9:54AM
- Benzinga Pro's Top 5 Stocks To Watch For Thursday, January 12, 2023: DAL, PFE, C, RBLX, MNSTBenzinga Newsdesk - Jan 12, 2023, 9:00AM
- Oramed Pharmaceuticals shares are trading lower after the company announced the ORA-D-013-1 trial did not meet its primary endpoint.Benzinga Newsdesk - Jan 12, 2023, 8:51AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Jan 12, 2023, 8:06AM
- Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving PremarketLisa Levin - Jan 12, 2023, 7:54AM
- Canaccord Genuity Downgrades Oramed Pharmaceuticals to HoldBenzinga Newsdesk - Jan 12, 2023, 6:49AM
- Oramed Pharma Shares Sink After Diabetes Candidate Fails In Phase 3 StudyVandana Singh - Jan 12, 2023, 6:19AM
- Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market SessionLisa Levin - Jan 12, 2023, 6:01AM
- Oramed Pharmaceuticals Shares Fall 70% Premarket After Company Reported Wednesday, Its Diabetes Trial Missed Primary EndpointCharles Gross - Jan 12, 2023, 5:15AM
- Reported Late Wednesday, Oramed Pharmaceuticals Announces Top-line Results From Phase 3 Trial Of ORMD-0801 For The Treatment Of Type 2 Diabetes; The ORA-D-013-1 Trial Did Not Meet Its Primary EndpointBenzinga Newsdesk - Jan 12, 2023, 12:42AM